Pathophysiologic and pharmacologic approaches in heart failure with preserved ejection fraction induced experimentally by pressure-overload and obesity

被引：0
|
作者：
Pop, C. [1 ]
Stoicescu, L. [2 ]
Muntean, D. M. [3 ]
Stefan, M. G. [4 ]
Gal, A. F. [5 ]
Lauzier, B. [6 ]
Morgovan, C. [7 ]
Kiss, B. [4 ]
Loghin, F. [4 ]
Mogosan, C. [1 ]
Ghibu, S. M. [1 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Physiol & Pathophysiol, Fac Pharm, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Cardiol, Med Clin 5, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Technol & Biopharm, Fac Pharm, Cluj Napoca, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, Dept Toxicol, Fac Pharm, Cluj Napoca, Romania
[5] Univ Agr Sci & Vet Med, Dept Cell Biol Histol & Embryol, Fac Vet Med, Cluj Napoca, Romania
[6] Inst Thorax, Nantes, France
[7] Lucian Blaga Univ, Preclin Dept, Fac Med, Sibiu, Romania
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1471
引用
收藏
页码：270 / 271
页数：2
相关论文
共 50 条
  • [1] A Rat Model of Heart Failure With Preserved Ejection Fraction Induced by Pressure Overload
    Sun, Shu-Yu
    Campbell, Barry
    Da Cunha, Valdeci
    Hong, Xuening
    Huang, Chin-Hu
    Kennan, Richard
    Ping, Xiaoli
    Shen, Xiaolan
    Small, Kersten
    Yang, Liming
    Zhao, Huawei
    Zheng, Shuqin
    Madwed, Jeffrey B.
    CIRCULATION RESEARCH, 2016, 119
  • [2] Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction
    Peters, Anthony E.
    DeVore, Adam D.
    CARDIOLOGY CLINICS, 2022, 40 (04) : 473 - 489
  • [3] Pharmacologic Management of Heart Failure with Preserved Ejection Fraction
    Huang, Dana
    Cheng, Judy W. M.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (12) : 1933 - 1945
  • [4] Obesity and heart failure with preserved ejection fraction
    Leowattana, Wattana
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (15) : 1591 - 1593
  • [5] Obesity and Heart Failure with Preserved Ejection Fraction
    Koutroumpakis, Efstratios
    Kaur, Ramanjit
    Taegtmeyer, Heinrich
    Deswal, Anita
    HEART FAILURE CLINICS, 2021, 17 (03) : 345 - 356
  • [6] Pharmacologic Heart Rate Modulation in Heart Failure With Preserved Ejection Fraction
    Eynde, Jef Van den
    Schuermans, Art
    Honigberg, Michael C.
    De Bruaene, Alexander Van
    Verbrugge, Frederik H.
    JACC-HEART FAILURE, 2023, 11 (08) : 1032 - 1033
  • [7] Endothelial Dysfunction A Pathophysiologic Factor in Heart Failure With Preserved Ejection Fraction
    Lam, Carolyn S. P.
    Brutsaert, Dirk L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (18) : 1787 - 1789
  • [8] Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    Packer, Milton
    Zile, Michael R.
    Kramer, Christopher M.
    Baum, Seth J.
    Litwin, Sheldon E.
    Menon, Venu
    Ge, Junbo
    Weerakkody, Govinda J.
    Ou, Yang
    Bunck, Mathijs C.
    Hurt, Karla C.
    Murakami, Masahiro
    Borlaug, Barry A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [9] Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
    Kirkman, Danielle L.
    Bohmke, Natalie
    Billingsley, Hayley E.
    Carbone, Salvatore
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [10] Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity
    Wagner, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (25): : 2398 - 2398
12345